KOCAA
Knights of Columbus Asset Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-30,922
| Closed | -$53.5K | – | 403 |
|
|
2024
Q2 | $53.5K | Hold |
30,922
| – | – | ﹤0.01% | 373 |
|
|
2024
Q1 | $73.9K | Sell |
30,922
-30,922
| -50% | -$73.9K | 0.01% | 348 |
|
|
2023
Q4 | $206K | Buy |
61,844
+30,922
| +100% | +$103K | 0.01% | 313 |
|
|
2023
Q3 | $116K | Buy |
+30,922
| New | +$116K | 0.01% | 339 |
|
|
2021
Q1 | – | Sell |
-145,647
| Closed | -$2.53M | – | 326 |
|
|
2020
Q4 | $2.53M | Sell |
145,647
-19
| -0% | -$330 | 0.27% | 131 |
|
|
2020
Q3 | $2.67M | Buy |
145,666
+6,941
| +5% | +$127K | 0.33% | 104 |
|
|
2020
Q2 | $2.48M | Buy |
138,725
+440
| +0.3% | +$7.86K | 0.3% | 108 |
|
|
2020
Q1 | $2.24M | Buy |
138,285
+70,089
| +103% | +$1.14M | 0.28% | 109 |
|
|
2019
Q4 | $1.23M | Buy |
+68,196
| New | +$1.23M | 0.11% | 302 |
|